You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (377)

Journals (0)

1-10 of 377 results for Adverse drug experience reports

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: The Evaluation of Postmarketing Adverse Drug Experience Reports at FDA: Part I

Retricted access

Research article

First published 1993-10

The Evaluation of Postmarketing Adverse Drug Experience Reports at FDA: Part I

Joyce M. Johnson, L. Ann Tanner, David Barash

Therapeutic Innovation & Regulatory Science

Select article: Safety Signals from Adverse Drug Experience Reports at FDA: Part II

Retricted access

Research article

First published 1993-10

Safety Signals from Adverse Drug Experience Reports at FDA: Part II

Joyce M. Johnson, L. Ann Tanner, David Barash

Therapeutic Innovation & Regulatory Science

Select article: Completeness of Adverse Drug Experience Reporting by Manufacturers to the FDA

Retricted access

Research article

First published 1991-10

Completeness of Adverse Drug Experience Reporting by Manufacturers to the FDA

Annie L. Britt, Deanne E. Knapp, Charles Anello [...]

Therapeutic Innovation & Regulatory Science

Select article: Adverse Drug Experience Communications and Reporting Industry Perspective: Regulations and Practice

Retricted access

Research article

First published 1991-1

Adverse Drug Experience Communications and Reporting Industry Perspective: Regulations and Practice

G. Edward Collins

Therapeutic Innovation & Regulatory Science

Select article: Experience with an Adverse Drug Reaction Reporting Program in a Neurology Specialty Clinic

Retricted access

Research article

First published 2002-2

Experience with an Adverse Drug Reaction Reporting Program in a Neurology Specialty Clinic

Melody Ryan, Mary Lea Gora-Harper, Frank Caldwell

Annals of Pharmacotherapy

Select article: Electronic Reporting of Adverse Event Data to the Food and Drug Administration: The Experiences of Glaxo Wellcome and Zeneca as Participants in the Adverse Event Reporting System Pilot Project

Retricted access

Other

First published 1999-10

Electronic Reporting of Adverse Event Data to the Food and Drug Administration: The Experiences of Glaxo Wellcome and Zeneca as Participants in the Adverse Event Reporting System Pilot Project

Mark Blake, Vlasta Pinkston

Therapeutic Innovation & Regulatory Science

Select article: Completeness of Adverse Drug Experience Reporting to the FDA: II. A Comparison of Manufacturer and Direct Reports on New Molecular Entities

Retricted access

Research article

First published 1994-1

Completeness of Adverse Drug Experience Reporting to the FDA: II. A Comparison of Manufacturer and Direct Reports on New Molecular Entities

Annie L. Britt, Deanne E. Knapp

Therapeutic Innovation & Regulatory Science

Select article: Discussion Panel: What Can Validly Be Done with Spontaneous Adverse Drug Experience Reports? *

Retricted access

Other

First published 1989-4

Discussion Panel: What Can Validly Be Done with Spontaneous Adverse Drug Experience Reports? *

Harry A. Guess

Therapeutic Innovation & Regulatory Science

Select article: Clinical Trial Adverse Drug Experience Reporting Requirements in the Major Countries and a Simplified Approach toward Meeting These Requirements

Retricted access

Other

First published 1992-10

Clinical Trial Adverse Drug Experience Reporting Requirements in the Major Countries and a Simplified Approach toward Meeting These Requirements

Max W. Talbott, Ellen Kelso

Therapeutic Innovation & Regulatory Science

Select article: Investigational Adverse Experience Reporting

Retricted access

Research article

First published 1987-7

Investigational Adverse Experience Reporting

Robert A. Michalak

Therapeutic Innovation & Regulatory Science

1
2
3
•••
38
10 / page

Article type

Publication date

Subjects

Access